UCLA

Pharma company acquires faculty-founded biotech firm for $537M

Business success story Agensys is acquired by Astellas Pharma Inc.

Print
Comments

Published Nov 28, 2007 2:43 PM



A business success story has both UCLA and a team of the university's enterprising scientists envisioning a brighter future for cancer research and patient care.

In 1996, a unique collaboration of leading UCLA scientists led by Arie Belldegrun founded the biotechnology company Agensys Inc. — and the company now stands to reap $537 million through an acquisition by Astellas Pharma Inc., making Agensys one of the largest Los Angeles-based private biotech firms poised to tackle therapeutic, fully human monoclonal antibody oncology research and drug development.

See the complete story in UCLA Today Online.

Comments

MOST POPULAR

Most Tweeted

    Range: Jan 03, 2021 – Present

      Range: Dec 04, 2020 – Present

        Range: Oct 20, 2020 – Present